Building a Complete IVD Sample-to-Result Workflow

Date: August 19, 2020
Time: 8:00 am PDT / 11:00 am EDT

IVD developer SpeeDx shares its experience building a complete sample-to-result workflow for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

This joint UgenTec & Thermo Fisher Scientific webinar will be hosted by GenomeWeb on Wednesday August 19th 2020, at 11am Eastern Time.  A recording will be made available on this webpage.


Charles Cartwright, PhD

Vice President, Scientific Affairs, SpeeDx Pty.Ltd.


James Grayson

Senior Field Application Scientist, UgenTec


Marina Berreta

Business Development Manager, Life Sciences,
Thermo Fisher Scientific


SpeeDx VP of Scientific Affairs Charles Cartwright will be sharing the story of how they partnered with UgenTec and instrument service providers including Thermo Fisher to bring unique assay solutions to the clinical diagnostic market.

Charles Cartwright, PhD - VP of Scientific Affairs, SpeeDx
What you'll learn

An IVD manufacturer's experience in building a sample-to-result workflow


Data analysis software has become an integral component of in vitro diagnostic assays in general, and molecular diagnostic tests in particular. The ability to provide a software solution for end users that accurately reports results, identifies technical issues, and can be integrated with a laboratory’s information systems can be as important in the final decision about whether to adopt a given platform as analytical and clinical performance data.